Neuroendocrine characteristics in malignant lung tumors: implications for diagnosis, treatment, and prognosis.
Senderovitz
T
T
Medical Department P, Bispebjerg Hospital, Copenhagen, Denmark.
Skov
B G
BG
Hirsch
F R
FR
D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy; D015816:Cell Adhesion Molecules, Neuronal / Q000032:analysis; D053379:Chromogranin A; D002864:Chromogranins / Q000032:analysis; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000188:drug therapy; D018358:Neuroendocrine Tumors / Q000175:diagnosis* / Q000188:drug therapy; D010751:Phosphopyruvate Hydratase / Q000378:metabolism; D011379:Prognosis
D015816:Cell Adhesion Molecules, Neuronal; D053379:Chromogranin A; D002864:Chromogranins; D010751:Phosphopyruvate Hydratase